Paracetamol: A Sweet Solution for Patients and the Planet
A groundbreaking initiative is challenging the status quo in healthcare, offering a win-win scenario for both patients and the environment.
A team of dedicated clinicians from Swansea Bay has embarked on a mission to revolutionize the way paracetamol is administered to young patients. The project, led by Consultant Anaesthetists and their colleagues, has uncovered a simple yet impactful solution: switching from intravenous (IV) to oral paracetamol for children undergoing planned surgery.
But here's the twist: this change isn't just about convenience. It's a powerful statement on sustainability and cost-effectiveness, without compromising patient care.
Previously, children under general anaesthetic for surgery would receive paracetamol through an IV canula in their hand. But the project's findings revealed that oral paracetamol, whether in liquid or tablet form, provides the same pain relief when patients wake up from surgery. And this is where it gets interesting: oral paracetamol is significantly more cost-effective and environmentally friendly than its IV counterpart.
The environmental impact of this switch is astonishing. The project estimates that avoiding IV paracetamol for pediatric planned surgery could save the equivalent of over 23,000 miles of driving per year in environmental impact. That's a huge reduction in carbon footprint!
Dr. Tereza Soskova, one of the leading Consultant Anaesthetists, highlights the financial and environmental benefits: 'Using oral paracetamol leads to substantial cost savings, with oral tablets being 24 times less expensive than IV paracetamol. Moreover, IV administration results in up to 12 times higher carbon emissions.'
The project, aptly named IMPROVE, has already made a significant impact. In 2024, 90% of paracetamol administrations for over 1,300 pediatric patients were intravenous. But a simple switch to oral paracetamol could have saved 9,190kg of eCO2, equivalent to driving over 23,000 miles in a petrol car, and £1,150 in costs.
And this is the part most people miss: the healthcare sector is a major contributor to global greenhouse gas emissions, with pharmaceuticals playing a significant role. Paracetamol, being one of the most widely used medications, offers a unique opportunity to make a substantial difference.
The IMPROVE project is now set to expand into adult planned surgery across multiple hospitals, aiming to amplify its positive impact. By doing so, they hope to inspire a broader conversation about sustainable healthcare practices.
What do you think? Is this a sweet solution for both patients and the planet, or are there hidden challenges? Share your thoughts below!
